Status:
COMPLETED
The Effect of Growth Factor on Implant Osseointegration
Lead Sponsor:
Uğur Can ÜNLÜGENÇ
Collaborating Sponsors:
Mustafa Kemal University
Conditions:
Bone Loss, Alveolar
Resorption, Bone
Eligibility:
All Genders
38-58 years
Phase:
NA
Brief Summary
In this study, concentrated growth factor obtained by centrifuging the patient's own blood and advanced platelet-rich fibrin liquids were applied to the implant cavity and surface. Thus, it was aimed ...
Detailed Description
This study was conducted in accordance with the Helsinki declaration on 32 patients who applied to Hatay Mustafa Kemal University Faculty of Dentistry Department of Oral and Maxillofacial Surgery to h...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- \- Having no systemic disorder,
- Not being pregnant or breastfeeding,
- Having no smoking habit,
- Lack of continuous drug use due to chronic disease,
- No infection in the implant site and adjacent teeth,
- No previous implant or any augmentation procedure in the implant site,
- Adequate bone height and thickness of the implant site,
- The patient's acceptance and signing the informed consent form specific to our study describing the aim, duration, advantages and possible complications of the study.
- Among the inclusion criteria in the study, no distinction was made between men and women, and the patients without these criteria were not included in the study.
Exclusion
Key Trial Info
Start Date :
April 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2021
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04879446
Start Date
April 10 2020
End Date
March 15 2021
Last Update
May 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ugur Can Unlugenc
Hatay, Mustafa Kemal University Hatay, Turkey, 31060, Turkey (Türkiye), 31060